Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from 223Ra-dichloride to new horizons for therapeutic response assessment

E. Bombardieri; Laura Evangelista; G. L. Ceresoli; Francesco Boccardo

doi:10.1007/s00259-015-3189-0

Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from ²²³Ra-dichloride to new horizons for therapeutic response assessment

E. Bombardieri, Laura Evangelista, G. L. Ceresoli, Francesco Boccardo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	5-7
Number of pages	3
Journal	European Journal of Pediatrics
Volume	43
Issue number	1
DOIs	https://doi.org/10.1007/s00259-015-3189-0
Publication status	Published - Jan 1 2016

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1007/s00259-015-3189-0

Cite this

Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients : from ²²³Ra-dichloride to new horizons for therapeutic response assessment. / Bombardieri, E.; Evangelista, Laura; Ceresoli, G. L.; Boccardo, Francesco.

In: European Journal of Pediatrics, Vol. 43, No. 1, 01.01.2016, p. 5-7.

Research output: Contribution to journal › Article › peer-review

@article{887f166cb3a34c73affc48d27f427a41,

title = "Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from 223Ra-dichloride to new horizons for therapeutic response assessment",

author = "E. Bombardieri and Laura Evangelista and Ceresoli, {G. L.} and Francesco Boccardo",

year = "2016",

month = jan,

day = "1",

doi = "10.1007/s00259-015-3189-0",

language = "English",

volume = "43",

pages = "5--7",

journal = "European Journal of Pediatrics",

issn = "0340-6199",

publisher = "Springer Berlin Heidelberg",

number = "1",

}

TY - JOUR

T1 - Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients

T2 - from 223Ra-dichloride to new horizons for therapeutic response assessment

AU - Bombardieri, E.

AU - Evangelista, Laura

AU - Ceresoli, G. L.

AU - Boccardo, Francesco

PY - 2016/1/1

Y1 - 2016/1/1

UR - http://www.scopus.com/inward/record.url?scp=84951907583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951907583&partnerID=8YFLogxK

U2 - 10.1007/s00259-015-3189-0

DO - 10.1007/s00259-015-3189-0

M3 - Article

VL - 43

SP - 5

EP - 7

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 1

ER -

Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from 223Ra-dichloride to new horizons for therapeutic response assessment

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

Nuclear medicine and the revolution in the modern management of castration-resistant prostate cancer patients: from ²²³Ra-dichloride to new horizons for therapeutic response assessment